By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Immune Pharmaceuticals, Inc. 

150 Broadway
Suite 1801
New York  New York  10038  U.S.A.
Phone: 646-937-1941 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Immune Pharmaceuticals, Inc. Secures Funding Of Up To $21.5 Million From Institutional Investors 7/30/2015 11:35:14 AM
Vista Partners Initiates Coverage On Immune Pharmaceuticals, Inc. (NasdaqCM: IMNP); $6.00 Price Target 7/24/2015 7:58:41 AM
Immune Pharmaceuticals, Inc. Joins The Russell Microcap Index 7/17/2015 6:34:57 AM
Immune Pharmaceuticals, Inc. To Present bertilimumab At The International Eosinophil Society Workshop On Personalized Medicine 7/13/2015 7:24:55 AM
Immune Pharmaceuticals, Inc. Amends Pain Licensing Agreement 7/8/2015 6:38:15 AM
Immune Pharmaceuticals, Inc. Signs License & Research Agreement For AmiKet Nano 6/29/2015 6:34:27 AM
Immune Pharmaceuticals, Inc. Initiates Phase II Clinical Trials With Bertilimumab In Ulcerative Colitis And Bullous Pemphigoid 6/26/2015 6:26:37 AM
Immune Pharmaceuticals, Inc. Expands Immuno-Dermatology Development Portfolio With Topical Nano-Formulated Cyclosporine A 6/10/2015 6:50:41 AM
Immune Pharmaceuticals, Inc. To Present At Goldman, Sachs & Co. Immuno-Oncology Business Development (BD&L) And Investment Forum In Chicago And At Marcum Conference In New York 5/28/2015 7:41:20 AM
Immune Pharmaceuticals, Inc. Reports First Quarter 2015 Financial Results; Bertilimumab Phase II Trials Ready To Enroll Patients 5/18/2015 10:27:21 AM
1234567
//-->